Department of Radiology

Publications

2020

Tahmi M, Rippon B, Palta P, Soto L, Ceballos F, Pardo M, et al. Brain Amyloid Burden and Resting-State Functional Connectivity in Late Middle-Aged Hispanics. Front Neurol. 2020;11:529930.

Waterhouse NN, Kothari PJ, Dooley M, Hu B, de Leon MJ, Babich J, et al. Synthesis of [1-C]Butanol via a facile solid phase extraction protocol. Appl Radiat Isot. 2020;159:109078.

Gabr MT, Barbault F. First dual binder of microRNA-146a and monomeric tau: a novel approach for multitargeted therapeutics for neurodegenerative diseases. Chem Commun (Camb). 2020;56(67):9695-9698.

Karakatsanis NA, Abgral R, Trivieri MG, Dweck MR, Robson PM, Calcagno C, et al. Hybrid PET- and MR-driven attenuation correction for enhanced F-NaF and F-FDG quantification in cardiovascular PET/MR imaging. J Nucl Cardiol. 2020;27(4):1126-1141.

Milak MS, Rashid R, Dong Z, Kegeles LS, Grunebaum MF, R Ogden T, et al. Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial. JAMA Netw Open. 2020;3(8):e2013211.

Gabr MT, Peccati F. Dual Targeting of Monomeric Tau and α-Synuclein Aggregation: A New Multitarget Therapeutic Strategy for Neurodegeneration. ACS Chem Neurosci. 2020;11(14):2051-2057.

Baboli M, Winters KV, Freed M, Zhang J, Kim SG. Evaluation of metronomic chemotherapy response using diffusion and dynamic contrast-enhanced MRI. PLoS One. 2020;15(11):e0241916.

Ebani EJ, Kaplitt MG, Wang Y, Nguyen TD, Askin G, J Chazen L. Improved targeting of the globus pallidus interna using quantitative susceptibility mapping prior to MR-guided focused ultrasound ablation in Parkinson's disease. Clin Imaging. 2020;68:94-98.

Rollick NC, Gadinsky NE, Klinger CE, Kubik JF, Dyke JP, Helfet DL, et al. The effects of dual plating on the vascularity of the distal femur. Bone Joint J. 2020;102-B(4):530-538.

Vedvyas Y, McCloskey JE, Yang Y, Min IM, Fahey TJ, Zarnegar R, et al. Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy. Sci Rep. 2020;10(1):12733.